In this Issue:
Hydroxyurea + anagrelide in ET
Melphalan + dexamethasone in light-chain amyloidosis
Post-SCT DLI-induced limited GVHD improves survival in relapsed AML
Aprepitant as antiemetic with high-dose melphalan for SCT conditioning
Single/double UBC transplants in AML with different myeloablative conditioning
RT to bulky disease in elderly aggressive B-cell lymphoma
Omitting RT in early PET-ve stage I/II HL increases early relapse risk
Omacetaxine for CML
Ultralow-dose IL-2 for GVHD prophylaxis after allogeneic SCT
R-CHOP ±surgical resection in intestinal DLBCL
Please login below to download this issue (PDF)